Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese

NCT03995550 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Portfolio proritisation

Conditions

Healthy

Interventions

DRUG: LEO 142397
DRUG: Placebo

Sponsor

LEO Pharma